Lukej Burchill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SGLT2 inhibitors not only were safe in adult patients with congenital heart disease who develop heart failure but also were associated with reduced hospitalizations.

United statesUniversity medical centerAnastasiad egorovaLukej burchillJournal of the american college cardiologyEuropean society of cardiologyDepartment of cardiovascular medicineLeiden university medical centerAmerican collegeEuropean societyCardiovascular medicineMayo clinicHeart failureSglt2 inhibitorsOdium glucose transporter 2 inhibitorsOdium glucose co transporter 2 inhibitors